Please assess the completion status of the following clinical trial:

Trial Title: Value of Functional Magnetic Resonance Imaging of Hepatocellular Carcinoma After Transarterial Chemoembolization or Transarterial Radioembolization

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Informed Consent as documented by signature (Appendix Informed Consent Form)~* Male and Female patients ≥18 years of age~* Patients with HCC according to imaging findings and/or histology and scheduled for TACE or TARE~Exclusion Criteria:~* Women who are pregnant or breast feeding,~* Please note that female participants who are surgically sterilised / hysterectomised or post-menopausal for longer than 2 years are not considered as being of child bearing potential.~* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant,~* Previous enrolment into the current study,~* Patients with impaired renal function (estimated glomerular filtration rate \<30 ml/min)~* Patients with non-MRI compatible metallic or electronic implants, devices or metallic foreign bodies (cardiac pacemaker, shrapnel, cochlea implants, neurostimulator, or other non-MRI compatible implants).~* Tumor-directed therapy (i.e. systemic chemotherapy) between transarterial therapy and 3-months follow-up MRI exam

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- post-TAE (Type: None): None
- post-TARE (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).